BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29116407)

  • 1. Fatigue- and health-related quality-of-life in anemic patients with lymphoma or multiple myeloma.
    Gascón P; Arranz R; Bargay J; Ramos F
    Support Care Cancer; 2018 Apr; 26(4):1253-1264. PubMed ID: 29116407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of darbepoetin alfa in alleviating fatigue and the effect of fatigue on quality of life in anemic patients with lymphoproliferative malignancies.
    Littlewood TJ; Kallich JD; San Miguel J; Hendricks L; Hedenus M
    J Pain Symptom Manage; 2006 Apr; 31(4):317-25. PubMed ID: 16632079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of the European CANCER ANAEMIA SURVEY.
    Birgegård G; Gascón P; Ludwig H
    Eur J Haematol; 2006 Nov; 77(5):378-86. PubMed ID: 17044835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from five randomized clinical trials.
    Cella D; Kallich J; McDermott A; Xu X
    Ann Oncol; 2004 Jun; 15(6):979-86. PubMed ID: 15151958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric properties of the Perform Questionnaire: a brief scale for assessing patient perceptions of fatigue in cancer.
    Baró E; Carulla J; Cassinello J; Colomer R; Mata JG; Gascón P; Gasquet JA; Rodríguez CA; Valentín V
    Support Care Cancer; 2011 May; 19(5):657-66. PubMed ID: 20432046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of the PERFORM questionnaire to measure fatigue in cancer patients with anemia: a prospective, observational study.
    Gascón P; Rodríguez CA; Valentín V; Mata JG; Carulla J; Cassinello J; Colomer R; Baró E
    Support Care Cancer; 2013 Nov; 21(11):3039-49. PubMed ID: 23793142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Epoetin-beta on anemia and health-related quality of life in cancer patients: a prospective observational study using the generic 15D instrument.
    Mäenpää J; Puistola U; Riska H; Sintonen H; Saarni O; Juvonen E; Kellokumpu-Lehtinen PL
    Anticancer Res; 2014 May; 34(5):2325-9. PubMed ID: 24778039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatigue in cancer patients compared with fatigue in the general United States population.
    Cella D; Lai JS; Chang CH; Peterman A; Slavin M
    Cancer; 2002 Jan; 94(2):528-38. PubMed ID: 11900238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies.
    Straus DJ; Testa MA; Sarokhan BJ; Czuczman MS; Tulpule A; Turner RR; Riggs SA
    Cancer; 2006 Oct; 107(8):1909-17. PubMed ID: 16977654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of anemia correction with health related quality of life in patients not on dialysis.
    Alexander M; Kewalramani R; Agodoa I; Globe D
    Curr Med Res Opin; 2007 Dec; 23(12):2997-3008. PubMed ID: 17958944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population.
    Cella D; Zagari MJ; Vandoros C; Gagnon DD; Hurtz HJ; Nortier JW
    J Clin Oncol; 2003 Jan; 21(2):366-73. PubMed ID: 12525531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-weekly epoetin-beta improves hemoglobin levels in cancer patients with chemotherapy-induced anemia: A randomized, double-blind, dose-finding study.
    Morishima Y; Ogura M; Yoneda S; Sakai H; Tobinai K; Nishiwaki Y; Minami H; Hotta T; Ezaki K; Ohe Y; Yokoyama A; Tsuboi M; Mori K; Watanabe K; Ohashi Y; Hirashima K; Saijo N;
    Jpn J Clin Oncol; 2006 Oct; 36(10):655-61. PubMed ID: 16987908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationships among physiologic variables, quality of life, and fatigue in patients with multiple myeloma.
    Booker R; Olson K; Pilarski LM; Noon JP; Bahlis NJ
    Oncol Nurs Forum; 2009 Mar; 36(2):209-16. PubMed ID: 19273410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dilemma: Correlation Between Serum Level of Hepcidin and IL-6 in Anemic Myeloma Patients.
    Ibricevic-Balic L; Icindic-Nakas E; Hasic S; Kiseljakovic E; Sofo-Hafizovic A; Balic S
    Med Arch; 2016 Dec; 70(6):429-432. PubMed ID: 28210014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric properties and measurement equivalence of the Multidimensional Fatigue Syndrome Inventory- Short Form (MFSI-SF) amongst breast cancer and lymphoma patients in Singapore.
    Chan A; Lew C; Wang XJ; Ng T; Chae JW; Yeo HL; Shwe M; Gan YX
    Health Qual Life Outcomes; 2018 Jan; 16(1):20. PubMed ID: 29351803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.
    Gabrilove JL; Cleeland CS; Livingston RB; Sarokhan B; Winer E; Einhorn LH
    J Clin Oncol; 2001 Jun; 19(11):2875-82. PubMed ID: 11387360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Intervention with epoetin alfa during platinum-based chemotherapy: an analysis of quality-of-life results of a multicenter, randomized, controlled trial compared with population normative data.
    Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
    Oncologist; 2006 Feb; 11(2):197-205. PubMed ID: 16476840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy.
    Quirt I; Robeson C; Lau CY; Kovacs M; Burdette-Radoux S; Dolan S; Tang SC; McKenzie M; Couture F;
    J Clin Oncol; 2001 Nov; 19(21):4126-34. PubMed ID: 11689580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased hemoglobin levels and improved quality-of-life assessments during epoetin alfa treatment in anemic cancer patients: results of a prospective, multicenter German trial.
    Reinhardt U; Tulusan A; Angermund R; Lutz H;
    Oncologist; 2005 Mar; 10(3):225-37. PubMed ID: 15793226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-reported outcomes after acute nonvariceal upper gastrointestinal hemorrhage.
    Bager P; Dahlerup JF
    Scand J Gastroenterol; 2014 Aug; 49(8):909-16. PubMed ID: 24945872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.